SHERIEDAN GRANNAN: Open Payments
NPI 1417326075 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 39 payments from 19 companies in 2025. Trend: 2023 $704 · 2024 $503 · 2025 $784
Food & beverage: $763Education: $21
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $218 |
| Supernus Pharmaceuticals, Inc. | 4 | $75 |
| ABBVIE INC. | 2 | $48 |
| Lundbeck LLC | 2 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
Products named: BREZTRI, AIRSUPRA, REXULTI, Qelbree, UBRELVY, Jornay PM, EVENITY, Cologuard Collection Kit.
Industry payments across WY — which companies pay providers there.
